SUIT-003 Ce1;ce2U;ce3Rot;ce4S;ce5Ama: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
(34 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
{{MitoPedia | {{MitoPedia | ||
|abbr= | |abbr=ceS | ||
|description=[[File: | |description=[[File:Ce1;ce2U;ce3Rot;ce4S;ce5Ama.png|200px]] | ||
|info= | |info='''B''' '''[[SUIT-003]]''' CCP(S) | ||
|application=O2 | |||
}} | }} | ||
{{MitoPedia concepts | {{MitoPedia concepts | ||
|mitopedia concept=SUIT protocol | |mitopedia concept=SUIT protocol, SUIT B | ||
}} | }} | ||
::: | ::: '''[[SUIT protocol pattern]]:''' linear monodirectional cell [[coupling-control protocol]] (ceCCP) | ||
:::: In many cases, oligomycin inhibits subsequently measured | |||
== R;L;E format_(S) == | |||
[[File:R;L;E format_(S).jpg|200px]] In the diagrams of coupling-control protocols for intact cells (ceCCP), the steps may be replaced by the respiratory states. | |||
:::* '''1ceU vs. 1ceOmy''' | |||
:::: In many cases, oligomycin inhibits subsequently measured ET capacity ([[Cell ergometry |Gnaiger E (2015) Cell ergometry and OXPHOS. Mitochondr Physiol Network 2015-01-18]]). The CCP without oligomycin, therefore, yields a more reliable estimate of ET capacity compared to the CCP with oligomycin. |
Latest revision as of 16:33, 3 June 2020
- high-resolution terminology - matching measurements at high-resolution
SUIT-003 Ce1;ce2U;ce3Rot;ce4S;ce5Ama
Description
Abbreviation: ceS
Reference: B SUIT-003 CCP(S)
O2k-Application: O2
MitoPedia concepts:
SUIT protocol,
SUIT B
- SUIT protocol pattern: linear monodirectional cell coupling-control protocol (ceCCP)
R;L;E format_(S)
In the diagrams of coupling-control protocols for intact cells (ceCCP), the steps may be replaced by the respiratory states.
- 1ceU vs. 1ceOmy
- In many cases, oligomycin inhibits subsequently measured ET capacity (Gnaiger E (2015) Cell ergometry and OXPHOS. Mitochondr Physiol Network 2015-01-18). The CCP without oligomycin, therefore, yields a more reliable estimate of ET capacity compared to the CCP with oligomycin.